Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fractyl Health (GUTS) Cash from Operations (2023 - 2025)

Fractyl Health's Cash from Operations history spans 3 years, with the latest figure at 21336000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Operations fell 25.26% year-over-year to 21336000.0, compared with a TTM value of 90328000.0 through Dec 2025, down 37.86%, and an annual FY2025 reading of 90328000.0, down 37.86% over the prior year.
  • Cash from Operations for Q4 2025 was 21336000.0 at Fractyl Health, up from 22714000.0 in the prior quarter.
  • The five-year high for Cash from Operations was 9550000.0 in Q1 2023, with the low at 25079000.0 in Q1 2025.
  • Average Cash from Operations over 3 years is 16556000.0, with a median of 17536500.0 recorded in 2024.
  • Biggest YoY gain for Cash from Operations was 13.14% in 2025; the steepest drop was 114.15% in 2025.
  • Tracing GUTS's Cash from Operations over 3 years: stood at 10599000.0 in 2023, then tumbled by 60.71% to 17034000.0 in 2024, then dropped by 25.26% to 21336000.0 in 2025.
  • Per Business Quant, the three most recent readings for GUTS's Cash from Operations are 21336000.0 (Q4 2025), 22714000.0 (Q3 2025), and 21199000.0 (Q2 2025).